Objective: To compare the efficacy and safety of 1 % Feracrylum gel with 0.5% Cetrimide cream in preventing infection in patients with minor traumatic wound treated on outpatient basis.

Study Design: Randomized, open-label, single-centre, comparative trial to study the efficacy and safety of Investigational Medicinal Product (IMP) (1% Feracrylum Gel) and Reference Medicinal Product (RMP) (0.5% Cetrimide Cream) in patients with minor traumatic wound.

Adult patients of either gender with minor traumatic wound, who as per the clinical judgment of the treating physician, do NOT require hospitalization and should be treated on outpatient basis, will be screened for the study. After applying the inclusion and exclusion criteria, the qualifying patients will be randomized 1:1 to receive either IMP or RMP at the time of initial dressing and subsequently at each dressing change.

Sample Size: Total 60 patients who will complete Visit 2 of the study

Efficacy Parameters: Primary - Physician Global Impression (PGI) score on wound condition at Visit 2 based on: 1) Discharge 2) Local Edema 3) Local Tenderness

Secondary – 1) Change in the bacteriological flora on the wound at Visit 2 compared to Visit 1 2) PGI on wound condition at Visit 3 based on Discharge, Local Edema 3) Local Tenderness, Ease of dressing change at Visit 2 and 3

Safety parameters: 1) Vital parameters (Pulse rate, BP, respiratory and body temperature) will be measured at the scheduled visits 2) Adverse event monitoring: Incidence and severity of any adverse event including allergic reactions observed during the study will be monitored and recorded in CRF